Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zydus
Fierce Biotech
Zydus' phase 3 win tees up filing to challenge Gilead and Ipsen
The win in primary biliary cholangitis clears the path to an FDA filing to establish the company as a challenger to Gilead, Intercept and Ipsen.
Nick Paul Taylor
Aug 29, 2025 10:59am
State AGs unveil opioid settlements totaling $720M
Jul 10, 2025 4:39pm
Agenus transfers pair of CA plants to Zydus as part of $141M pact
Jun 3, 2025 9:32am
Roche files patent suit to fend off potential Evrysdi generics
Nov 20, 2024 9:44am
Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia
Sep 13, 2024 8:53am
Zydus hit with FDA warning letter flagging glass contamination
Sep 11, 2024 11:42am
